29 results on '"Laubender, Ruediger Paul"'
Search Results
2. Supplementary Table 1 from Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials
3. Association between left ventricular mechanical dyssynchrony with myocardial perfusion and functional parameters in patients with left bundle branch block
4. Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer
5. Intra- and inter-cycle variability of anti-Müllerian hormone (AMH) levels in healthy women during non-consecutive menstrual cycles: the BICYCLE study
6. Hyperdense basilar artery sign—a reliable sign of basilar artery occlusion
7. Selection of within‐run quality control rules for laboratory biomarkers
8. Intra- and inter-cycle variability of anti-Müllerian hormone (AMH) levels in healthy women during non-consecutive menstrual cycles: the BICYCLE study.
9. INTRA- AND INTER-CYCLE VARIABILITY OF ANTI-MÜLLERIAN HORMONE (AMH) LEVELS IN HEALTHY WOMEN MEASURED WITH ELECSYS AMH PLUS IMMUNOASSAY: THE BICYCLE STUDY
10. Mirror movements in healthy humans across the lifespan: effects of development and ageing
11. Anisotropy of transcallosal motor fibers indicates functional impairment in children with periventricular leukomalacia
12. KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer
13. Surrogate endpoints in second-line treatment for mCRC: A systematic literature-based analysis from 23 randomised trials
14. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans
15. Quantitative analysis of the impact of deepness of response on post-progression survival time following first-line treatment in patients with mCRC.
16. Deepness of response: A quantitative analysis of its impact on post-progression survival time after first-line treatment in patients with mCRC.
17. Phosphorylated ERK (pERK) as biomarker in patients with advanced pancreatic cancer treated with erlotinib within a randomized phase III trial (AIO-PK0104).
18. Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials
19. Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer
20. Correlation of hand-foot skin reaction (HFS) with treatment efficacy in pancreatic cancer (PC) patients (pts) treated with gemcitabine/capecitabine plus erlotinib: A subgroup analysis from the AIO-PK0104 randomized, cross-over phase III trial in advanced PC.
21. Improved early prediction of individual prognosis for patients with mCRC: Joint modeling of tumor shrinkage with volume data for PFS and OS.
22. Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the AIO KRK 0104 trial.
23. Capecitabine (cape)-associated hand-foot skin reaction (HFS) as a clinical predictor of improved survival in patients (pts) with colorectal cancer.
24. Tumor assessments according to RECIST versus volumetry: Impact on early changes in tumor size in metastatic colorectal cancer (mCRC).
25. Hyperdense basilar artery sign—a reliable sign of basilar artery occlusion
26. Surrogate endpoints in second-line treatment for mCRC: A systematic literature-based analysis from 23 randomised trials.
27. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
28. Cetuximab-based or bevacizumab-based first-line treatment in patients with KRASp.G13D-mutated metastatic colorectal cancer
29. Two-marker combinations for preoperative discrimination of benign and malignant ovarian masses.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.